1105 Comparative Effectiveness of Standalone Middle Meningeal Artery Embolization versus Surgical Evacuation in Patients With Non-Acute Subdural Hematomas

View at publisher Summarise with VIRAT
Authors: Ignacio Mesina-Estarrón, Niels Pacheco-Barrios, Sahin Hanalioglu, Nanthiya Sujijantarat, Christopher J. Stapleton, Aman B. Patel, Robert William Regenhardt, Kevin T. Huang
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Adjunctive middle meningeal artery embolization (MMAE) has been shown to reduce the recurrence of non-acute subdural hematomas (NASDH), but its effectiveness as a standalone therapy remains to be established. METHODS: We conducted a propensity score-matched cohort study on 265 patients with NASDH who underwent either sMMAE or surgical evacuation. The primary outcome was reintervention due to hematoma resurgence. Secondary outcomes included length of hospitalization, new neurological deficits, cardiorespiratory, neurological, and other medical adverse events. RESULTS: After matching, 85 patients were allocated to each group. The median age was 73 years, and 20% were female. There were no baseline differences in clinical characteristics at presentation. During a median follow-up of 72 days in the sMMAE group and 59 days in the surgical group, the incidence rate of reintervention did not differ between the two treatments (IRR 1.38, p = .41). Median length of hospitalization was shorter in the sMMAE group (4 days vs. 6 days, p =.003). No differences were observed in new neurological deficits at 30 days (RR 0.85, p = .71), nor risk of cardiorespiratory (RR .50, p = .327), or neurologic adverse events (RR 0.66, p = .65). Patients treated with sMMAE had a lower risk of other medical adverse events compared to surgery (1.1% vs. 15.2%, RR = .07, p = .013). CONCLUSIONS: Patients who undergo sMMAE may benefit from a shorter hospitalization and a lower risk of medical adverse events compared to open surgical treatment, without experiencing increased risk of recurrence. Larger studies are warranted to establish the effectiveness of sMMAE in the management of NASDH and to identify the subset of patients that are most likely to benefit from this treatment modality.

Fields of Study & Subjects

Neurosurgical Procedures and Complications Intracerebral and Subarachnoid Hemorrhage Research Spinal Hematomas and Complications

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
207–207
Publication date
26 March 2026
Language
EN